National Health Investors (NHI) is a publicly traded Real Estate sector company. As of May 21, 2026, NHI trades at $77.48 with a market cap of $3.68B and a P/E ratio of 24.95. NHI moved +1.00% today. Year to date, NHI is +1.56%; over the trailing twelve months it is +3.68%. Its 52-week range spans $65.13 to $91.38. Analyst consensus is strong buy with an average price target of $89.33. Rallies surfaces NHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NHI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NHI recently traded at $77.48. Market cap is $3.68B. P/E ratio is 24.95. Revenue is $401.46M.
| Metric | Value |
|---|---|
| Price | $77.48 |
| Market Cap | $3.68B |
| P/E Ratio | 24.95 |
| EPS | $3.11 |
| Dividend Yield | 0.92% |
| 52-Week High | $91.38 |
| 52-Week Low | $65.13 |
| Volume | 8 |
| Avg Volume | 0 |
| Revenue (TTM) | $401.46M |
| Net Income | $146.72M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $375.63M | $140.79M | $3.03 |
| 2024 | $335.18M | $136.64M | $3.14 |
| 2023 | $319.83M | $134.38M | $3.13 |
| 2022 | $278.19M | $65.50M | $1.48 |
4 analysts cover NHI: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $89.33.